Andy Black reappointed as Kinapse Chief Executive
pharmafile | September 27, 2010 | News story | | Kinapse
27 September, 2010
London, UK
Andy Black reappointed as Kinapse Chief Executive
The Board of Directors of Kinapse Ltd. today announced that Andy Black has been appointed to succeed Shalabh Kumar as Chief Executive Officer, effective immediately.
Andy Black said “I am pleased and honoured to once again take on the Chief Executive role. My first priorities will be to ensure that Kinapse’s clients receive outstanding service, and that our people have every opportunity to fulfill their enormous potential as we continue to expand our services and operations.”
Kinapse Ltd.
About Kinapse
Kinapse provides consulting and outsourcing services to the global life sciences industries.
Our clients include many of the world’s leading pharmaceutical, biotechnology, medical device and specialty pharmaceutical companies, government organisations and life sciences service providers.
Kinapse specialises in addressing the challenges of life sciences. We understand the complex issues faced throughout the life sciences value chain and offer innovative insights, advice and service delivery to our clients.
Contact:
info@kinapse.com, +44 (0)208 946 7600
Related Content
Service Insight: Discovery metrics – creating the right balance
SERVICE INSIGHTMetrics can be powerful tools for driving performance in organisations and have proliferated in …
The Project Management Office – Accelerating Project Management Maturity
Success in the life sciences industry depends on allocation of scarce resource to the right …
Offshore outsourcing in Regulatory Affairs and Pharmacovigilance
Based on Kinapse’s direct experience, we explore the emerging environment for regulatory and pharmacovigilance offshore …






